FERRING PHARMACEUTICALS, INC. v. BRAINTREE LABORATORIES, INC., 13-12553-NMG. (2016)
Court: District Court, D. Massachusetts
Number: infdco20170103449
Visitors: 9
Filed: Dec. 01, 2016
Latest Update: Dec. 01, 2016
Summary: ORDER NATHANIEL M. GORTON , District Judge . The motion of Ferring Pharmaceuticals, Inc. for a continuance of the trial (Docket No. 595) is DENIED with one minor caveat. Trial will commence on Monday, January 23, 2017 at 9:00 a.m. and, because time limits will be imposed, will not last anywhere near "three to four weeks". The previously set deadlines for pre-trial events are all postponed by one week and the final pre-trial conference is rescheduled for Thursday, January 19, 2017 at 3:00
Summary: ORDER NATHANIEL M. GORTON , District Judge . The motion of Ferring Pharmaceuticals, Inc. for a continuance of the trial (Docket No. 595) is DENIED with one minor caveat. Trial will commence on Monday, January 23, 2017 at 9:00 a.m. and, because time limits will be imposed, will not last anywhere near "three to four weeks". The previously set deadlines for pre-trial events are all postponed by one week and the final pre-trial conference is rescheduled for Thursday, January 19, 2017 at 3:00 ..
More
ORDER
NATHANIEL M. GORTON, District Judge.
The motion of Ferring Pharmaceuticals, Inc. for a continuance of the trial (Docket No. 595) is DENIED with one minor caveat. Trial will commence on Monday, January 23, 2017 at 9:00 a.m. and, because time limits will be imposed, will not last anywhere near "three to four weeks". The previously set deadlines for pre-trial events are all postponed by one week and the final pre-trial conference is rescheduled for Thursday, January 19, 2017 at 3:00 p.m.
SO ORDERED.
Source: Leagle
